StonvexLoading…
StonvexStonvexStonvexCore line items from RMNI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Q3 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $314.54M | $209.87M | $106.75M | $319.39M |
Operating Income | $-47.01M | $2.59M | $3.36M | $32.22M |
Net Income | $-42.93M | $169.00K | $1.32M | $16.71M |
EPS (Diluted) | $-0.48 | $0.00 | $0.01 | $0.19 |
Total Assets | $343.84M | $367.37M | $351.19M | $334.98M |
Total Liabilities | $420.62M | $403.49M | $387.51M | $388.02M |
Cash & Equivalents | $119.49M | $134.20M | $129.00M | $108.23M |
Free Cash Flow OCF − CapEx | $-3.87M | $15.32M | $9.92M | $9.96M |
Shares Outstanding | 90.84M | 90.70M | 89.93M | 89.32M |